J. Joseph Kim

2.1k total citations
13 papers, 635 citations indexed

About

J. Joseph Kim is a scholar working on Immunology, Epidemiology and Infectious Diseases. According to data from OpenAlex, J. Joseph Kim has authored 13 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in J. Joseph Kim's work include Immunotherapy and Immune Responses (5 papers), Virology and Viral Diseases (3 papers) and Mosquito-borne diseases and control (3 papers). J. Joseph Kim is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Virology and Viral Diseases (3 papers) and Mosquito-borne diseases and control (3 papers). J. Joseph Kim collaborates with scholars based in United States, India and Canada. J. Joseph Kim's co-authors include David B. Weiner, Niranjan Y. Sardesai, Amir Sada Khan, Kar Muthumani, Kate E. Broderick, Jean Boyer, Jian Yan, Matthew P. Morrow, Mark L. Bagarazzi and Jessica C. Lee and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and The Journal of Infectious Diseases.

In The Last Decade

J. Joseph Kim

13 papers receiving 610 citations

Peers

Countries citing papers authored by J. Joseph Kim

Since Specialization

Citations

This map shows the geographic impact of J. Joseph Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Joseph Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Joseph Kim more than expected).

Fields of papers citing papers by J. Joseph Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Joseph Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Joseph Kim. The network helps show where J. Joseph Kim may publish in the future.

Co-authorship network of co-authors of J. Joseph Kim

This figure shows the co-authorship network connecting the top 25 collaborators of J. Joseph Kim. A scholar is included among the top collaborators of J. Joseph Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Joseph Kim. J. Joseph Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	A randomized study to evaluate the safety and immunogenicity of a pentavalent meningococcal vaccine 2024 ·npj Vaccines ·Yoonjin Kim, (unknown), Kyung‐Sang Yu, SeungHwan Lee, (unknown), J. Joseph Kim, (unknown), Jaeseong Oh	2
2	Immunotherapy of prostate cancer using novel synthetic DNA vaccines targeting multiple tumor antigens 2021 ·Genes & Cancer ·Devivasha Bordoloi, Peng Xiao, Hyeree Choi, (unknown), Alfredo Perales‐Puchalt, Makan Khoshnejad, J. Joseph Kim, Laurent Humeau, Alagarsamy Srinivasan, David B. Weiner, Kar Muthumani	12
3	Synthetic DNA-Encoded Monoclonal Antibody Delivery of Anti–CTLA-4 Antibodies Induces Tumor Shrinkage In Vivo 2018 ·Cancer Research ·Elizabeth K. Duperret, (unknown), Regina Stoltz, Ami Patel, Megan C. Wise, Alfredo Perales‐Puchalt, Trevor R.F. Smith, Kate E. Broderick, Emma L. Masteller, J. Joseph Kim, Laurent Humeau, Kar Muthumani, David B. Weiner	49
4	Rapid response to an emerging infectious disease – Lessons learned from development of a synthetic DNA vaccine targeting Zika virus 2018 ·Microbes and Infection ·Sagar B. Kudchodkar, Hyeree Choi, Emma L. Reuschel, Rianne Esquivel, (unknown), Moonsup Jeong, Joel N. Maslow, Charles C. Reed, S. M. White, J. Joseph Kim, Gary Kobinger, Pablo Tebas, David B. Weiner, Kar Muthumani	20
5	Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy 2017 ·Clinical Cancer Research ·Matthew P. Morrow, Kimberly A. Kraynyak, Albert J. Sylvester, Michael Dallas, Dawson Knoblock, Jean Boyer, Jian Yan, Russell Vang, Amir Sada Khan, Laurent Humeau, Niranjan Y. Sardesai, J. Joseph Kim, Stanley A. Plotkin, David B. Weiner, Cornelia L. Trimble, Mark L. Bagarazzi	34
6	Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody 2017 ·Cancer Immunology Immunotherapy ·Kar Muthumani, (unknown), Sagar B. Kudchodkar, Alfredo Perales‐Puchalt, Hyeree Choi, Sangya Agarwal, (unknown), Emma L. Reuschel, Faraz I. Zaidi, Elizabeth K. Duperret, Megan C. Wise, Kimberly A. Kraynyak, Kenneth E. Ugen, Niranjan Y. Sardesai, J. Joseph Kim, David B. Weiner	31
7	Broad cross-protective anti-hemagglutination responses elicited by influenza microconsensus DNA vaccine 2017 ·Vaccine ·Jian Yan, Matthew P. Morrow, (unknown), Trina Racine, Charles C. Reed, Amir Sada Khan, Kate E. Broderick, J. Joseph Kim, Gary Wong, Niranjan Y. Sardesai, David B. Weiner	16
8	Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus 2016 ·The Journal of Infectious Diseases ·Kar Muthumani, Peter D. Block, Seleeke Flingai, (unknown), Itta Krishna Chaaithanya, Colleen Tingey, Megan C. Wise, Emma L. Reuschel, Christopher Chung, (unknown), Gopalsamy Sarangan, Padma Srikanth, Amir Sada Khan, Paluru Vijayachari, Niranjan Y. Sardesai, J. Joseph Kim, Kenneth E. Ugen, David B. Weiner	69
9	Safety, bioavailability, and pharmacokinetics of VGX‐1027—A novel oral anti‐inflammatory drug in healthy human subjects 2015 ·Clinical Pharmacology in Drug Development ·Jessica C. Lee, Stanley Menacherry, Malissa Diehl, Mary Giffear, Carla White, (unknown), Mark L. Bagarazzi, Kar Muthumani, Jean Boyer, Vipin Agarwal, Ferdinando Nicoletti, (unknown), J. Joseph Kim, David B. Weiner, Niranjan Y. Sardesai	11
10	Immunotherapy Against HPV16/18 Generates Potent T _H 1 and Cytotoxic Cellular Immune Responses 2012 ·Science Translational Medicine ·Mark L. Bagarazzi, Jian Yan, Matthew P. Morrow, Xuefei Shen, Raphaëlle Parker, Jessica C. Lee, Mary Giffear, Panyupa Pankhong, Amir Sada Khan, Kate E. Broderick, Christine Knott, Feng Lin, Jean Boyer, Ruxandra Draghia‐Akli, (unknown), J. Joseph Kim, David B. Weiner, Niranjan Y. Sardesai	229
11	An optimized SIV DNA vaccine can serve as a boost for Ad5 and provide partial protection from a high-dose SIVmac251 challenge 2012 ·Vaccine ·Natalie A. Hutnick, (unknown), Lauren A. Hirao, (unknown), Bernadette Ferraro, Amir Sada Khan, Mark G. Lewis, Christopher J. Miller, Andrew J. Bett, Danilo R. Casimiro, Niranjan Y. Sardesai, J. Joseph Kim, John W. Shiver, David B. Weiner	13
12	A DNA Vaccine against Chikungunya Virus Is Protective in Mice and Induces Neutralizing Antibodies in Mice and Nonhuman Primates 2011 ·PLoS neglected tropical diseases ·Karthik Mallilankaraman, Devon J. Shedlock, (unknown), Omkar U. Kawalekar, Paolo Fagone, (unknown), Bernadette Ferraro, Jennifer Stabenow, Paluru Vijayachari, Senthil G. Sundaram, Nagarajan Muruganandam, Gopalsamy Sarangan, Padma Srikanth, Amir Sada Khan, Mark G. Lewis, J. Joseph Kim, Niranjan Y. Sardesai, Kar Muthumani, David B. Weiner	145
13	Anti-cancer activity of the HIV accessory molecule viral protein R (Vpr): Delivery as a DNA expression plasmid or biologically active peptides 2010 ·Vaccine ·Kar Muthumani, (unknown), Omkar U. Kawalekar, Richard Heller, J. Joseph Kim, David B. Weiner, Kenneth E. Ugen	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact